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Introduction
Transporters, expressed in several tissues, including liver and kidney, are important proteins governing the pharmacokinetics of many drugs. Transporter-mediated uptake from the portal vein into hepatocytes is the first step in their hepatic elimination.
Thus, the changes in hepatic uptake clearance can directly affect overall intrinsic hepatic clearance. Organic anion transporting polypeptide (Oatp) family transporters are involved in the efficient uptake of several organic anions into the liver. In rodents, multiple Oatp isoforms such as Oatp1a1, 1a4, 1b2, and 2b1 are expressed on the sinusoidal membrane in hepatocytes (Cheng et al., 2005) . Among them, Oatp1a4 encoded by Slco1a4 (solute carrier organic anion transporter family, member 1a4) is predominantly expressed in the liver and brain. A number of studies for Oatp1a4 in vitro have demonstrated that it accepts not only anionic compounds, such as HMG-CoA reductase inhibitors (pitavastatin, pravastatin, and rosuvastatin), and -lactam antibiotics (nafcillin, cefmetazole, and cefazolin), but also neutral cardiac glycosides (digoxin and ouabain) and zwitterionic compounds such as fexofenadine (Noé et al., 1997; Cvetkovic et al., 1999; Reichel et al., 1999; Tokui et al., 1999; Ho et al., 2006; Nakakariya et al., 2008; Ose et al., 2010) . Oatp1a4 has at least two recognition sites, one for digoxin (neutral compound) and taurocholate (organic anion), and the other for estradiol-17-D-glucuronide (Sugiyama et al., 2002) . In particular, among rodent Oatp family transporters, digoxin is selectively recognized by Oatp1a4 (Noé et al., 1997; Reichel et al., 1999; Cattori et al., 2000 Cattori et al., , 2001 . Several groups have generated knockout mice for Oatp isoforms and investigated their roles in the hepatic uptake and subsequent pharmacokinetics of substrates.
The K p,liver of pravastatin decreased
This article has not been copyedited and formatted. The final version may differ from this version. (Chen et al., 2008; Zaher et al., 2008) . Gong et al. reported that the plasma area under the curve of the concentration-time profile (AUC) of estradiol-17-D-glucuronide was 55% larger in female Slco1a1 -/-mice than that in wild-type mice, with a 50% reduction in K p,liver ; however, knockout of Slco1a4 did not affect the plasma AUC or K p,liver of estradiol-17-D-glucuronide, while the plasma AUC of dibromosulfophthalein was 3-fold higher in both Slco1a1 -/-and Slco1a4 -/-mice compared with that in wild-type mice (Gong et al., 2011) . Moreover, several studies have reported that the changes in pharmacokinetics and tissue distribution of pravastatin, atorvastatin, simvastatin, rosuvastatin, and carboxydichlorofluorescein in Oatp1a/1b cluster knockout mice showed a significant reduction of hepatic uptake because of the lack of major hepatic Oatp isoforms (Iusuf et al., 2012 (Iusuf et al., , 2013 Higgins et al., 2014) . However, to date, the quantitative contribution of Oatp1a4 to the drug disposition and subsequent pharmacokinetics of substrate drugs in rodents has not been clarified. Ose et al. demonstrated that the brain-to-blood transport of pitavastatin, rosuvastatin, pravastatin, and taurocholate after microinjection into the cerebral cortex was decreased significantly in
Slco1a4
-/-mice compared with wild-type mice (Ose et al., 2010) . The purpose of the present study was to evaluate the significant involvement of Oatp1a4 in the hepatic uptake in mice of substrate drugs, including digoxin (a selective substrate for Oatp1a4 among Oatp family transporters), with the use of Slco1a4 -/-mice.
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Materials and Methods
Chemicals
Ouabain, digoxin, BQ-123, rosuvastatin calcium salt, pravastatin sodium salt, and nafcillin sodium salt were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Fexofenadine hydrochloride was purchased from Sigma-Aldrich (St. Louis, MO).
Telmisartan was purchased from Tokyo Chemical Industry Co. (Tokyo, Japan). All other chemicals were commercially available, of reagent grade, and used without further purification.
Animals
Slco1a4 knockout (Slco1a4 The University of Tokyo (Tokyo, Japan).
Quantification of mRNA expression of various transporters in the murine liver
The mRNA levels of Slco1a1, Slco1a4, Slco1b2, Slco2b1, Abcc2, Abcc3, Abcb1a, Abcg2,  This article has not been copyedited and formatted. The final version may differ from this version. pravastatin, nafcillin, and telmisartan were determined using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) analysis.
LC-MS/MS analysis
A LC-MS/MS system comprising an Alliance 2695 separation module (Waters, Milford, MA) equipped with a Quattro Micro API tandem mass spectrometer was used for the analysis of ouabain, digoxin, fexofenadine, rosuvastatin, pravastatin, nafcillin, and telmisartan. The 
Pharmacokinetic analysis
Total clearance (CL tot ), biliary excretion clearance with regard to plasma concentration (CL bile,plasma ), and biliary excretion clearance with regard to liver concentration (CL bile,liver )
were calculated using the following equations:
CL bile, plasma = V bile /C p,ss (
CL bile, liver = V bile /C liver,ss
where C p,ss , V bile,ss , and C liver,ss represent the plasma concentration, biliary excretion rate, and liver concentration at steady state, respectively. In the present study, C p,ss and C liver,ss were defined as the plasma and liver concentrations of the parent compounds at 30 min (BQ-123), 60 min (ouabain), or 120 min (digoxin, fexofenadine, rosuvastatin, pravastatin, nafcillin, and telmisartan), judging from their time courses of plasma concentration. V bile,ss was calculated as the biliary excretion rate of ouabain and digoxin from 40 to 60 min and from 90 to 120 min, respectively. To calculate C liver,ss , the specific gravity of the liver was regarded as its liver concentration (ng/mL).
Statistical analysis
The means and standard deviations of mRNA expression level, drug concentration in the plasma and liver, and pharmacokinetic parameters were calculated for both wild-type and
Slco1a4
-/-mice. A Student two-tailed unpaired t test was used to identify significant differences. P < 0.05 was considered significant.
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Results
Analysis of mRNA expression levels of hepatic transporters in wild-type and
The mRNA expression levels of hepatic transporters in wild-type and Slco1a4 -/-mice are compared in Table 2 . As expected, Slco1a4 mRNA showed a significantly lower expression in Slco1a4 -/-mice, but no significant difference was observed in mRNA expression levels of other tested hepatic transporters between wild-type and Slco1a4
-/-mice.
Time profiles for plasma concentrations of substrate drugs in wild-type and
Slco1a4 -/-mice after constant intravenous infusion
The plasma concentrations of ouabain, digoxin, BQ-123, fexofenadine, rosuvastatin, pravastatin, nafcillin, and telmisartan after constant intravenous infusion into wild-type and Slco1a4 -/-mice are shown in Fig. 1 and 
Discussion
To elucidate the role of Oatp1a4 in the hepatic uptake of substrate drugs, we determined the hepatic clearance and distribution of Oatp1a4 substrates using Slco1a4 -/-mice. According to the previous report (Cheng et al., 2005) , mRNA expression level of Oatp1a4 in the liver was significantly higher in female than male. Thus, to sensitively characterize the importance of Oatp1a4-mediated transport, we decided to use female mice in the current study. We found that the K p,liver of ouabain and digoxin were decreased significantly in Slco1a4 -/-mice. In experiments using Xenopus oocytes expressing rodent Oatp transporters, digoxin was found to be transported selectively via Oatp1a4 (Noé et al., 1997; Reichel et al., 1999; Cattori et al., 2000 Cattori et al., , 2001 . By contrast, ouabain was recognized by Oatp1a1 and Oatp1a4 with higher affinity to Oatp1a4 (Oatp1a1; K m = 1700-3000 M, Oatp1a4; K m = 470 M (Bossuyt et al., 1996; Eckhardt et al., 1999; Noé et al., 1997) ). The observed decrease of K p,liver of these compounds in Slco1a4 -/-mice can be explained by the relatively higher contribution of Oatp1a4 to their overall uptake. By contrast, the identical uptake of digoxin by primary cultured hepatocytes isolated from wild-type and Slco1a4 -/-mice was reported (Gong et al., 2011) . This apparent discrepancy can be explained, at least in part, by the high affinity of digoxin for rat Oatp1a4 (K m = 0.24 M). In the previous in vitro study, 1 M of digoxin was used in the incubation medium, which may partially saturate Oatp1a4-mediated transport. Conversely, in our study, the plasma unbound concentration of digoxin was far below its K m ; therefore, Oatp1a4-mediated hepatic uptake was expected to be clearly observed. 
where f B and f T represent the protein unbound fraction in blood and tissue, respectively.
Based on these equations, the decrease in the transport activity of Oatp1a4-mediated hepatic uptake results in a decrease in PS inf , and subsequently, CL H,int and K p,liver should be decreased. Actually, the K p,liver of ouabain and digoxin were decreased in Slco1a4 -/-mice, whereas no differences were observed in the CL bile,liver between wild-type and Slco1a4 28% in wild-type mice, which was higher than that of digoxin (9%). Considering low metabolic clearance of digoxin in mice (Kawahara et al., 1999) , a hepatic elimination is more important for ouabain than digoxin. According to the previous reports, the relative contribution of CL H to CL tot of digoxin was 44.2% in C57BL/6 mice (Kawahara et al., 1999) , while that of ouabain was more than 74% in rats, although no data were available for mice (Meijer and van Monffoort, 2002) . In addition, the urinary recovery of ouabain in humans was 37% (Selden and Smith, 1972) , whereas 80% of digoxin was excreted into urine in an unchanged form (Aronson, 1980) . These results suggest that more digoxin than ouabain tends to be excreted into the urine. Calculating the glomerular filtration clearance of unbound drug (fu*GFR) for ouabain and digoxin in mouse, those of ouabain and digoxin are 13.3 and 10.9 mL/min; where fu for ouabain and digoxin, and GFR are 0.95 (rat), 0.78 (mouse) and 14 mL/min/kg (Davies and Morris, 1993; Kawahara et al., 1999; Meijer and van Monffoort, 2002) . Those were similar to the CL tot of ouabain and digoxin in Slco1a4 -/-mice, respectively. Therefore, the different change in the CL tot of ouabain and digoxin can be explained rationally by the different contribution of hepatic elimination to total clearance. (Taub et al., 2011) . In human hepatocytes, uptake of digoxin was partly mediated by saturable carrier(s), though no hepatic OATPs can transport digoxin (Kimoto et al., 2011) . Ouabain was recognized by OATP1B3 and OATP1A2 (Kullak-Ublick et al., 2001) . Though OATP1A2 shows the highest identity with mouse Oatp1a4 (73%) among human OATP isoforms, its protein expression was very low in human liver (Wegler et al., 2017) and mainly expressed in cholangiocytes (Lee et al., 2005) . Therefore, the species differences in transporter-mediated uptake of cardiac glycosides between humans and rodents need to be carefully discussed due to a lack of genetic and functional correspondence.
The plasma concentration of rosuvastatin was increased significantly in Slco1a4 -/-mice, and its K p,liver was decreased slightly. The K p,liver of rosuvastatin was decreased by approximately 50% in Slco1b2 -/-mice (DeGorter et al., 2012) . Moreover, K p,liver of rosuvastatin after intravenous administration was reduced 5-to 10-fold in Oatp1a/1b cluster knockout mice (Iusuf et al., 2013) . This reduction suggested that the hepatic uptake of rosuvastatin is mediated by Oatp1a/1b transporters including Oatp1b2, with a minor contribution of Oatp1a4.
By contrast, the K p,liver of BQ-123, fexofenadine, pravastatin, and nafcillin were not different between wild-type and Slco1a4 -/-mice. BQ-123, fexofenadine, and nafcillin are transported via multiple Oatp isoforms, Oatp1a1 and Oatp1b2, in addition to Oatp1a4
This article has not been copyedited and formatted. The final version may differ from this version. (Cvetkovic et al., 1999; Reichel et al., 1999; Cattori et al., 2001; Ho et al., 2006; Nakakariya et al., 2008) . No differences in their K p,liver were observed between wild-type and
Slco1a4
-/-mice, which suggests that contribution of Oatp1a4 to their hepatic uptake is not dominant. Pravastatin can be transported by Oatp1a1, Oatp1a4, and Oatp1b2 (Hsiang et al., 1999; Tokui et al., 1999; Sasaki et al., 2004) . The K p,liver of pravastatin was reduced 3-fold in Slco1b2 -/-mice (Zaher et al., 2008) and 10-to 200-fold in Oatp1a/1b cluster knockout mice (Iusuf et al., 2012; Higgins et al., 2014) . These results suggest that Oatp1a/1b transporters, at least Oatp1b2, contribute to the hepatic uptake of pravastatin.
About 90% of nafcillin uptake into isolated rat hepatocytes is mediated by Oatp1a4 based on a relative activity factor method (Nakakariya et al., 2008) . Although the exact reason for that discrepancy is unknown, it might be the result of species difference in the relative contribution of Oatp isoforms.
Unexpectedly, we found that the K p,liver of telmisartan was significantly increased in
-/-mice. The uptake of telmisartan in isolated rat hepatocytes is inhibited by digoxin in a concentration-dependent manner (Ishiguro et al., 2006) . Oatp1a4-mediated transport is completely inhibited by 100 M digoxin in rats, whereas Oatp1a1-mediated transport is not (Sugiyama et al., 2002) . Therefore, rat Oatp1a4 is considered to be partly involved in the hepatic uptake of telmisartan. Although the exact mechanism remains unknown, it is implied that hepatic influx clearance mediated by other transporters is increased and/or that the hepatic efflux clearance and metabolic clearance of telmisartan is decreased by knocking out the Slco1a4 gene, even though the mRNA expression levels of several typical hepatic transporters are unchanged in Slco1a4 -/-mice.
This article has not been copyedited and formatted. The final version may differ from this version. In conclusion, we clarified that the hepatic distribution of ouabain and digoxin is dominated by Oatp1a4 in mice, and that systemic clearance of ouabain is significantly reduced in Slco1a4 -/-mice because of the large contribution of its hepatic elimination.
These findings suggest that Oatp1a4 plays an important role in the hepatic uptake of neutral cardiac glycosides in mice.
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